Third in a series on ASC quality improvement.
As is common practice, patients at Delaware Surgery Center in Dover have always been asked about allergies to penicillin and other substances. But when some started having adverse reactions to the alternatives, the center’s staff looked for ways to improve results. They found that many times patients allergic to penicillin were given ciprofloxacin or vancomycin instead of a cephalosporin, due to the increased risk of a cross-sensitivity reaction. But research resulted in a new policy that allowed a return to the use of cephalosporins following thorough screening.
Not only did the change improve quality, but it also saved money and earned the center a national award.
Delaware Surgery Center has 4 ORs and 2 procedure rooms. Lynn Watts, RN, heads the performance-improvement committee. She recalls how in 2004 the committee noticed that variance reports, the incident reports generated for internal review, showed an increase in antibiotic reactions.
“In 2004, we had 10 variances for ciprofloxacin,” she says. “The pharmacist pointed out that was excessive. We thought maybe it was flow-rate related, so we told the nurses to use microdrip infusion sets.”
That only worked for a while; the number of reactions crept up again over the next 2 years. In 2006, the center conducted a performance improvement study and discovered that over a 3-month period, 7 of 31 patients receiving ciprofloxacin suffered adverse reactions. In 2007, during a repeat study, 8 of 33 patients who received ciprofloxacin had an adverse reaction, a rate the center deemed unacceptable.
Furthermore, of the 8 with reactions, 6 were also allergic to penicillin: the switch had done them no good.
Watts, in consultation with the lead anesthesiologist, Andrew Crell, MD, and staff surgeon Stephen Cooper, MD, did some research.
They learned, in essence, that what had begun as a good idea in surgical practice may have gone too far. Since the 1960s, medical science has known that penicillin and cephalosporins have similar molecular structures, and patients who are allergic to one are likely to have cross-sensitivity to the other.
Physicians began substituting other antibiotics for penicillin-allergic patients, primarily ciprofloxacin but also vancomycin.
There was a problem with that approach.
Ciprofloxacin and vancomycin are among the strongest antibiotics available. They are broad-spectrum and have been used as a last resort to fight otherwise intractable infections, including those from unknown sources, or organisms that have become resistant to traditional antibiotics.
Since the 1960s when the stronger drugs were first seen as an alternative to penicillin, the incidence of drug-resistant organisms has accelerated.
The Centers for Disease Control and Prevention’s Campaign to Prevent Antimicrobial Resistance recommends restricting use of broad-spectrum agents to serious infections (www.cdc.gov/drugresistance/healthcare).
What the Delaware staff found, however, was an increasing tendency to use the stronger drugs for prophylaxis prior to surgery.
“We don’t want patients to risk developing resistance to these drugs when many less-potent drugs are available for preventing postoperative infection,” Watts says.
What remained, Watts recalls, was the challenge of finding a way to screen surgical patients so overuse of antibiotics would cease, yet any patient truly at risk of allergic reaction or with any other clinical indication would receive an antibiotic of needed strength.
She read in Anesthesiology News that the severity and frequency of past experiences are instrumental in determining the risk of future reactions— but that meant questioning patients in greater detail than before.
She discovered that other health care organizations had developed screening tools and found an example Delaware was able to adapt for its own use. The questionnaire was in the form of an algorithm, or flow chart.
“It’s very simple, actually,” she says. “Each question leads to another based on the patient’s answer.”
The point, according to Watts, was to investigate thoroughly a patient’s reactive history.
For example, the questions cover a range of reactions, from anaphylactic shock to nausea. They also ask about the family history of reactions and time since the patient last experienced a reaction, if ever.
The reason, Watts explains, is that after 10 years, sensitivity tends to decrease significantly. So even with a history of penicillin reaction, “in most cases, we can give them cephalosporin without a reaction,” she says.
Under the new policy, if a patient reports an allergy to penicillin, a staff member administers the questionnaire, usually through a phone call, Watts notes. The patient’s answers become part of the medical record and are reviewed by Dr Crell, who then can make a recommendation to the surgeon. The surgeon has the final decision on the antibiotic to be used.
The result was a dramatic decrease in use of the strongest antibiotics, yet there have been no adverse reactions since the policy was instituted in 2008. Over a 15-month period, the performance improvement committee reviewed 80 records selected at random from those of 300 patients with reported penicillin allergies. They found only 2% had received ciprofloxacin, and 1% received vancomycin.
Meanwhile, the center has saved $2,000 annually by switching to lower-cost drugs. “In 2007, the center ordered 6 cases of Cipro. In 2008, we only ordered 1,” Watts recalls.
Watts described the new practice in a presentation in December 2009, when the center received an Innovations in Quality Improvement Award from the AAAHC Institute for Quality Improvement (AAAHC Institute), a subsidiary of the Accreditation Association for Ambulatory Health Care (AAAHC).
–Paula DeJohn
Bryson, E O. Lesson 261: Pre-anesthetic assessment of patient reporting allergy to penicillin. Anesthesiology News. March 2007. www.proceo.com/gateway/MSSM/references/Mar07.pdf
Implementing strategies to reduce surgical site infection. ACS Midas+. September/October 2005. www.midasplus.com/Docs/Issue4_CDS.pdf